Hungary vs Northern Africa and Western Asia: Proportion of the target population who received the final dose of
Hungary
75.0%
in 2024
Northern Africa and Western Asia
2.0%
in 2024
Hungary rank
32nd
Northern Africa and Western Asia rank
35th
Proportion of the target population who received the final dose of over time
- Hungary
- Northern Africa and Western Asia
How they compare
Hungary currently reports 75.0% against 2.0% in Northern Africa and Western Asia, a difference of 73.0%.
That makes Hungary's figure about 37.5 times Northern Africa and Western Asia's.
Across all 10 years both countries report, Hungary has been ahead every year.
Hungary ranks 32nd and Northern Africa and Western Asia ranks 35th of 107 countries.
Hungary has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hungary | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.4% | 1.0% | 72.4% | Hungary |
| 2020s | 78.0% | 1.8% | 76.2% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Hungary or Northern Africa and Western Asia?
- Hungary, at 75.0% against 2.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Hungary and Northern Africa and Western Asia?
- 73.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Northern Africa and Western Asia?
- 10 years are reported by both, from 2015 to 2024.
- How do Hungary and Northern Africa and Western Asia rank globally for proportion of the target population who received the final dose of?
- Hungary ranks 32nd and Northern Africa and Western Asia ranks 35th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.